A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
10/1998
10/02/1998	CA2232743A1 A tnf homologue, tl5
10/02/1998	CA2226910A1 Sialoadhesin family member-2 (saf-2)
10/01/1998	WO1998042855A1 Rapid production of autologous tumor vaccines by using hsv amplicon vectors
10/01/1998	WO1998042849A1 Keratinocyte derived kallikrein
10/01/1998	WO1998042847A2 Papilloma virus main capsid protein and the use thereof in diagnosis, therapy and vaccination
10/01/1998	WO1998042835A1 Human genes
10/01/1998	WO1998042834A1 Bi- or multifunctional molecules based on a dendroaspin scaffold
10/01/1998	WO1998042752A1 Immunotherapeutic ctla-4 binding peptides
10/01/1998	WO1998042742A1 Vp22 proteins and uses thereof
10/01/1998	WO1998042739A2 Secreted proteins and polynucleotides encoding them
10/01/1998	WO1998042738A1 87 human secreted proteins
10/01/1998	WO1998042729A2 Steroid sulfamates, method for the production and use thereof
10/01/1998	WO1998042725A1 Methods and compositions for diagnosis and treatment of breast cancer
10/01/1998	WO1998042696A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
10/01/1998	WO1998042662A1 Certain cyclic thio substituted acylaminoacid amide derivatives
10/01/1998	WO1998042381A1 Immobilized activity stabilized lhrh antagonist complexes, method for the production thereof
10/01/1998	WO1998042378A1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies
10/01/1998	WO1998042365A1 Ligand/lytic peptide compositions and methods of use
10/01/1998	WO1998042364A1 Ligand/lytic peptide compositions and methods of use
10/01/1998	WO1998042357A1 Use of an extract of alchemilli vulgaris
10/01/1998	WO1998042351A1 Difluoronucleoside phosphonic acids and derivatives thereof
10/01/1998	WO1998042339A1 Use of chelerythrine and radiation for tumor therapy
10/01/1998	WO1998042334A1 Leukotriene antagonists useful for treating squamous cell carcinoma
10/01/1998	WO1998042330A1 Methods and compositions for treatment of ovarian cancer
10/01/1998	WO1998042328A1 Di-aryl ethers and their derivatives as anti-cancer agents
10/01/1998	WO1998042296A2 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions
10/01/1998	WO1998042209A1 Decaffeinated mate extracts and the use thereof
10/01/1998	WO1998029555A3 Cytopathic viruses for therapy and prophylaxis of neoplasia
10/01/1998	WO1998024427A3 Compositions and methods for treating or preventing inflammatory diseases
10/01/1998	DE19712718A1 Immobilisierte und aktivitätsstabilisierte Komplexe von LHRH-Antagonisten und Verfahren zu deren Herstellung Immobilized and activity-stabilized complexes of LHRH antagonists and methods for their preparation
10/01/1998	DE19712488A1 Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben Steroidsulfamate, processes for their preparation and use thereof
10/01/1998	CA2484922A1 Liposomes containing oligonucleotides
10/01/1998	CA2287156A1 Rapid production of autologous tumor vaccines by using hsv amplicon vectors
10/01/1998	CA2285530A1 Di-aryl ethers and their derivatives as anti-cancer agents
10/01/1998	CA2285391A1 Methods and compositions for treatment of ovarian cancer
10/01/1998	CA2284992A1 Use of chelerythrine and radiation for tumor therapy
10/01/1998	CA2284687A1 Keratinocyte derived kallikrein
10/01/1998	CA2284642A1 Methods and compositions for diagnosis and treatment of breast cancer
10/01/1998	CA2284550A1 87 human secreted proteins
10/01/1998	CA2284263A1 Difluoronucleoside phosphonic acids and derivatives thereof
10/01/1998	CA2284095A1 Bi- or multifunctional molecules based on a dendroaspin scaffold
10/01/1998	CA2283932A1 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions
10/01/1998	CA2283794A1 Vp22 proteins and uses thereof
10/01/1998	CA2283631A1 Secreted proteins and polynucleotides encoding them
10/01/1998	CA2232461A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
09/1998
09/30/1998	EP0867513A2 Interleukin-1 beta converting enzyme apoptosis protease-10
09/30/1998	EP0867509A2 Tumor necrosis related receptor, TR5
09/30/1998	EP0867438A1 Rapamycin derivatives and their use, particularly as immunosuppressants
09/30/1998	EP0866865A1 Chimeric oligomers having an rna-cleavage activity
09/30/1998	EP0866857A1 E6 binding proteins
09/30/1998	EP0866852A1 Tissue-specific and target rna-specific ribozymes
09/30/1998	EP0866851A1 Tumour vaccine and process for the preparation thereof
09/30/1998	EP0866801A1 Cyclopeptolides
09/30/1998	EP0866800A2 Antineoplastic peptides
09/30/1998	EP0866790A1 3-benzylaminopyrrolidines and -piperidines as tachykinin receptor antagonists
09/30/1998	EP0866721A1 Targeted adenovirus vectors
09/30/1998	EP0866712A1 Antineoplastic methods and compositions employing optically pure (-)-fotemustine
09/30/1998	EP0866709A1 1,2,4-benzotriazine oxides formulations
09/30/1998	EP0781092A4 Method of sensitizing tumor cells with adenovirus e1a
09/30/1998	EP0542807B1 Use of 2-phenyl-1,2-benzisoselenazol-3(2h)-one
09/30/1998	CN1194667A Manipulation and detection of protein phosphatase 2C-PP2C alpha-expression in tumor cell for cancer therapy, prevention and detection
09/30/1998	CN1194647A Pyrrolopyrimidines and processes for preparation thereof
09/30/1998	CN1194583A Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and treating human malignancies
09/30/1998	CN1194271A Sulphur-35 labeled single clone antibody and its preparing method
09/30/1998	CN1194147A Anti-cancer medicinal composition and its preparing method
09/29/1998	US5814647 Use of troglitazone and related compounds for the treatment of the climacteric symptoms
09/29/1998	US5814630 Quinazoline compounds
09/29/1998	US5814620 Inhibition of neovascularization using vegf-specific oligonucleotides
09/29/1998	US5814608 S-fluoro-anthracyclines, processes for their preparation and pharmaceutical compositions containing them
09/29/1998	US5814480 Polynucleotide sequence, for detection of the polypeptide in a biological sample
09/29/1998	US5814464 Nucleic acids encoding TIE-2 ligand-2
09/29/1998	US5814340 Controlled release systems and low dose androgens
09/29/1998	US5814319 Solutions of water with plant extracts of aspalathus with carriers
09/29/1998	US5814317 Structural alterations of the EGF receptor gene in human gliomas
09/29/1998	US5814315 Methods for the suppression of neu mediated phenotype in tumors
09/29/1998	US5814314 Non-glycosylated, recombinant human IL 2 in reduced form
09/29/1998	US5814307 Synthesis of interleukins for cells
09/29/1998	US5814295 Determination of lymph nodes enriched in tumor reactive cells their proliferation and their use in adoptive cellular therapy
09/29/1998	CA2118032C Therapeutic conjugates of toxins and drugs
09/27/1998	CA2231055A1 Interleukin-1 beta converting enzyme like apoptosis protease-10
09/24/1998	WO1998041641A1 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors
09/24/1998	WO1998041635A1 Human tumorigenesis associated protein, htap
09/24/1998	WO1998041632A1 Human tumor suppressor
09/24/1998	WO1998041631A2 β-CATENIN, TCF-4, AND APC INTERACT TO PREVENT CANCER
09/24/1998	WO1998041629A2 Death domain containing receptor 5
09/24/1998	WO1998041624A1 Modulators of the function of receptors of the tnf/ngf receptor family
09/24/1998	WO1998041562A1 Non-antigenic branched polymer conjugates
09/24/1998	WO1998041542A1 Antiangiogenic drug to treat cancer, arthritis and retinopathy
09/24/1998	WO1998041540A1 Radiolabelled somatostatin receptor ligands for diagnosis and therapy
09/24/1998	WO1998041525A1 Pyrrolo[2,3d]pyrimidines and their use as tyrosine kinase inhibitors
09/24/1998	WO1998041512A1 Substituted 2-anilinopyrimidines useful as protein kinase inhibitors
09/24/1998	WO1998041500A1 2-alkyl-19-nor-vitamin d compounds
09/24/1998	WO1998041242A1 Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
09/24/1998	WO1998041238A2 Methods and kits for treating and diagnosing leiomyomas
09/24/1998	WO1998041236A1 Pharmaceutical composition for eliminating membrane-mediated cell resistance
09/24/1998	WO1998041231A1 Suppression of malignancy utilizing ribonucleotide reductase r1
09/24/1998	WO1998041212A1 New formulation
09/24/1998	WO1998041206A1 Novel carboxylic acid derivatives, their preparation and use in treating cancer
09/24/1998	WO1998041205A1 Cytochalasin and isoindolinone derivatives as inhibitors of angiogenesis
09/24/1998	CA2644454A1 Death domain containing receptor 5

1 ... 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 ... 2211